Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
BJU International|September 14, 2007
The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsyDaniela Colleselli, Jasmin Bektic, Georg Schaefer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 10, 2012
Potential of the gastric motility drug lorglumide in prostate cancer imagingAlexander Sturzu, Sumbla Sheikh, Uwe Klose, et al.
World Journal of Urology|March 13, 2012
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?Tilman Todenhöfer, Jörg Hennenlotter, Ursula Kühs, et al.
Disease Markers|August 18, 2018
Systemic Alterations of Wnt Inhibitors in Patients with Prostate Cancer and Bone MetastasesStefan Aufderklamm, Jörg Hennenlotter, Phillip Leidenberger, et al.
Urologic Oncology|August 2, 2015
Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1Steffen Rausch, Joerg Hennenlotter, Katharina Teepe, et al.
Central European Journal of Urology|February 11, 2015
Intracorporeal ileal ureter replacement using laparoscopy and roboticsAllen Sim, Tilman Todenhöfer, Johannes Mischinger, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 30, 2012
Evaluating the diagnostic and chemotherapeutic potential of vancomycin-derived imaging conjugatesSumbla Sheikh, Alexander Sturzu, Uwe Klose, et al.
World Journal of Urology|January 18, 2015
Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomyGeorgios Gakis, Theofanis Ngamsri, Steffen Rausch, et al.
BJU International|February 12, 2008
Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?Alexandre E Pelzer, Daniela Colleselli, Jasmin Bektic, et al.
BJU International|March 18, 2008
Clinical and pathological features of screen vs non-screen-detected prostate cancers: is there a difference?Alexandre E Pelzer, Daniela Colleselli, Jasmin Bektic, et al.
Pageof 16